Dual role of autophagy in HIV-1 replication and pathogenesis

AIDS Research and Therapy

M Scott Killian¹ 

[1] Department of Medicine, University of California San Francisco, Box 1270, 513, Parnassus Avenue, San Francisco, CA, 94143-1270, USA

关键词: Pathogenesis;    Antiretroviral therapy;    T cells;    Innate immunity;    Autophagy;    HIV;   

Others  :  789658
DOI  :  10.1186/1742-6405-9-16

 received in 2012-03-30, accepted in 2012-04-21,  发布年份 2012

【 授权许可】

   
2012 Killian; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Levy JA: HIV and the pathogenesis of AIDS. ASM Press, Washington, D.C; 2007.
• [2]Yang Z, Klionsky DJ: Eaten alive: a history of macroautophagy. Nat Cell Biol 2010, 12:814-822.
• [3]Tanida I: Autophagy basics. Microbiol Immunol 2011, 55:1-11.
• [4]Jung CH, Ro SH, Cao J, Otto NM, Kim DH: mTOR regulation of autophagy. FEBS Lett 2010, 584:1287-1295.
• [5]Xie Z, Klionsky DJ: Autophagosome formation: core machinery and adaptations. NatCell Biol 2007, 9:1102-1109.
• [6]Tong J, Yan X, Yu L: The late stage of autophagy: cellular events and molecular regulation. Protein Cell 2010, 1:907-915.
• [7]Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al.: TFEB links autophagy to lysosomal biogenesis. Science 2011, 332:1429-1433.
• [8]Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al.: Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
• [9]Lee JW, Park S, Takahashi Y, Wang HG: The association of AMPK with ULK1 regulates autophagy. PLoS One 2010, 5:e15394.
• [10]Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al.: Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009, 20:1981-1991.
• [11]Hosokawa N, Sasaki T, Iemura S, Natsume T, Hara T, Mizushima N: Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 2009, 5:973-979.
• [12]Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL, Mizushima N: FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 2008, 181:497-510.
• [13]Webber JL, Tooze SA: New insights into the function of Atg9. FEBS Lett 2010, 584:1319-1326.
• [14]Proikas-Cezanne T, Waddell S, Gaugel A, Frickey T, Lupas A, Nordheim A: WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 2004, 23:9314-9325.
• [15]Itakura E, Kishi C, Inoue K, Mizushima N: Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 2008, 19:5360-5372.
• [16]Weidberg H, Shvets E, Elazar Z: Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 2011, 80:125-156.
• [17]Velikkakath AK, Nishimura T, Oita E, Ishihara N, Mizushima N: Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. Mol Biol Cell 2012, 5:896-909.
• [18]Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T: Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001, 152:657-668.
• [19]Geng J, Klionsky DJ: The Atg8 and Atg12 ubiquitin-like conjugation systems inmacroautophagy. 'Protein modifications: beyond the usual suspects' reviewseries. EMBO Rep 2008, 9:859-864.
• [20]Itoh T, Fujita N, Kanno E, Yamamoto A, Yoshimori T, Fukuda M: Golgi-resident small GTPase Rab33B interacts with Atg16L and modulates autophagosome formation. Mol Biol Cell 2008, 19:2916-2925.
• [21]Yuan W, Stromhaug PE, Dunn WA Jr: Glucose-induced autophagy of peroxisomes in Pichia pastoris requires a unique E1-like protein. Mol Biol Cell 1999, 10:1353-1366.
• [22]Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z: LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 2010, 29:1792-1802.
• [23]Tanida I, Tanida-Miyake E, Komatsu M, Ueno T, Kominami E: Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p. J Biol Chem 2002, 277:13739-13744.
• [24]Hemelaar J, Lelyveld VS, Kessler BM, Ploegh HL: A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J Biol Chem 2003, 278:51841-51850.
• [25]Ganley IG, Wong PM, Gammoh N, Jiang X: Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 2011, 42:731-743.
• [26]Yang Z, Klionsky DJ: An overview of the molecular mechanism of autophagy. CurrTopMicrobiolImmunol 2009, 335:1-32.
• [27]Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, et al.: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
• [28]Barth S, Glick D, Macleod KF: Autophagy: assays and artifacts. J Pathol 2010, 221:117-124.
• [29]Yla-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL: Monitoring autophagy by electron microscopy in Mammalian cells. Methods Enzymol 2009, 452:143-164.
• [30]Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y: In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004, 15:1101-1111.
• [31]Mizushima N, Yoshimori T, Levine B: Methods in mammalian autophagy research. Cell 2010, 140:313-326.
• [32]Raught B, Gingras AC, Sonenberg N: The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 2001, 98:7037-7044.
• [33]Seglen PO, Gordon PB: 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. ProcNatlAcadSciUSA 1982, 79:1889-1892.
• [34]Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC: Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 2008, 4:849-950.
• [35]Kuma A, Matsui M, Mizushima N: LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 2007, 3:323-328.
• [36]Campbell GR, Spector SA: Hormonally active vitamin D3 (1alpha,25- dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011, 286:18890-18902.
• [37]Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P, Shen HM: Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010, 285:10850-10861.
• [38]Levine B, Mizushima N, Virgin HW: Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
• [39]Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, Wu L, Kominami E, Ueno T, Yamamoto A, et al.: Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. JCell Biol 2009, 186:255-268.
• [40]Uchil PD, Mothes W: HIV Entry Revisited. Cell 2009, 137:402-404.
• [41]Zhou D, Kang KH, Spector SA: Production of Interferon alpha by Human Immunodeficiency Virus Type 1 in Human Plasmacytoid Dendritic Cells Is Dependent on Induction of Autophagy. J Infect Dis 2012, 205:1258-1267.
• [42]Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ: Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
• [43]Eekels JJ, Sagnier S, Geerts D, Jeeninga RE, Biard-Piechaczyk M, Berkhout B: Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors. Virol J 2012, 9:69. BioMed Central Full Text
• [44]Zhou D, Spector SA: Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 2008, 22:695-699.
• [45]Espert L, Varbanov M, Robert-Hebmann V, Sagnier S, Robbins I, Sanchez F, Lafont V, Biard-Piechaczyk M: Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoSONE 2009, 4:e5787.
• [46]Wang X, Gao Y, Tan J, Devadas K, Ragupathy V, Takeda K, Zhao J, Hewlett I: HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4(+) T cells. Cell Signal 2012, 24:1414-1419.
• [47]Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, Codogno P, Biard-Piechaczyk M: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. JClinInvest 2006, 116:2161-2172.
• [48]Denizot M, Varbanov M, Espert L, Robert-Hebmann V, Sagnier S, Garcia E, Curriu M, Mamoun R, Blanco J, Biard-Piechaczyk M: HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008, 4:998-1008.
• [49]Molina L, Grimaldi M, Robert-Hebmann V, Espert L, Varbanov M, Devaux C, Granier C, Biard-Piechaczyk M: Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics 2007, 7:3116-3130.
• [50]Carter CA, Ehrlich LS: Cell biology of HIV-1 infection of macrophages. AnnuRevMicrobiol 2008, 62:425-443.
• [51]Roeth JF, Collins KL: Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. MicrobiolMolBiolRev 2006, 70:548-563.
• [52]Gregoire IP, Richetta C, Meyniel-Schicklin L, Borel S, Pradezynski F, Diaz O, Deloire A, Azocar O, Baguet J, Le Breton M, et al.: IRGM Is a Common Target of RNA Viruses that Subvert the Autophagy Network. PLoS Pathog 2011, 7:e1002422.
• [53]Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, et al.: Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology 2007, 4:66. BioMed Central Full Text
• [54]Terwilliger EF, Langhoff E, Gabuzda D, Zazopoulos E, Haseltine WA: Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1991, 88:10971-10975.
• [55]Abel PM, McSharry C, Galloway E, Ross C, Severn A, Toner G, Gruer L, Wilkinson PC: Heterogeneity of peripheral blood monocyte populations in human immunodeficiency virus-1 seropositive patients. FEMS Microbiol Immunol 1992, 5:317-323.
• [56]Li JC, Au KY, Fang JW, Yim HC, Chow KH, Ho PL, Lau AS: HIV-1 trans-activator protein dysregulates IFN-gamma signaling and contributes to the suppression of autophagy induction. AIDS 2011, 25:15-25.
• [57]Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS: HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 2010, 5:e11733.
• [58]Spector SA, Zhou D: Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS? Autophagy 2008, 4:704-706.
• [59]Au K, Li J, Yim H, Fang J, Lau A: PP1-095 HIV Tat modulation of IFN-g-induced expression of autophagy-associated genes in primary human blood macrophages. Cytokine 2009, 48:46-90.
• [60]Wu RF, Ma Z, Liu Z, Terada LS: Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation. Mol Cell Biol 2010, 30:3553-3568.
• [61]Killian MS, Levy JA: HIV/AIDS: 30 years of progress and future challenges. Eur J Immunol 2011, 41:3401-3411.
• [62]Munz C: Enhancing immunity through autophagy. Annu Rev Immunol 2009, 27:423-449.
• [63]Borrow P: Innate immunity in acute HIV-1 infection. Curr Opin HIV AIDS 2011, 6:353-363.
• [64]Delgado M, Singh S, de Haro S, Master S, Ponpuak M, Dinkins C, Ornatowski W, Vergne I, Deretic V: Autophagy and pattern recognition receptors in innate immunity. ImmunolRev 2009, 227:189-202.
• [65]Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
• [66]Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA: HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005, 343:256-266.
• [67]Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
• [68]Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A: Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007, 315:1398-1401.
• [69]Guiducci C, Ghirelli C, Marloie-Provost MA, Matray T, Coffman RL, Liu YJ, Barrat FJ, Soumelis V: PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. Journal of Experimental Medicine 2008, 205:315-322.
• [70]Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M: Single- stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol 2007, 178:7658-7666.
• [71]Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I: Direct effects of type I interferons on cells of the immune system. Clin Cancer Res 2011, 17:2619-2627.
• [72]Mikulak J, Gianolini M, Versmisse P, Pancino G, Lusso P, Verani A: Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS stimulated human macrophages. Virology 2009, 390:37-44.
• [73]Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, Green DR: Toll-like receptor signaling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
• [74]Rossi M, Young JW: Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005, 175:1373-1381.
• [75]English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, Alexander D, Leib D, Norbury C, Lippe R, Desjardins M: Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. NatImmunol 2009, 10:480-487.
• [76]Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R, Garcia E, Dinkins C, Leuba F, Wu L, et al.: Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 2010, 32:654-669.
• [77]Morris S, Swanson MS, Lieberman A, Reed M, Yue Z, Lindell DM, Lukacs NW: Autophagy-Mediated Dendritic Cell Activation Is Essential for Innate Cytokine Production and APC Function with Respiratory Syncytial Virus Responses. J Immunol 2011, 187:3953-3961.
• [78]Comber JD, Robinson TM, Siciliano NA, Snook AE, Eisenlohr LC: Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation. J Virol 2011, 85:6453-6463.
• [79]Martinson JA, Roman-Gonzalez A, Tenorio AR, Montoya CJ, Gichinga CN, Rugeles MT, Tomai M, Krieg AM, Ghanekar S, Baum LL, Landay AL: Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol 2007, 250:75-84.
• [80]Harris J, Master SS, De Haro SA, Delgado M, Roberts EA, Hope JC, Keane J, Deretic V: Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. Vet Immunol Immunopathol 2009, 128:37-43.
• [81]Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP: Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Research and Human Retroviruses 2006, 22:757-762.
• [82]Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L: Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
• [83]Massey DC, Parkes M: Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's disease. Autophagy 2007, 3:649-651.
• [84]Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A: NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nature Medicine 2010, 16:90-97.
• [85]Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Yuan L, Soares F, Chea E, Le Bourhis L, et al.: Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010, 11:55-62.
• [86]Stratton R, Slapak G, Mahungu T: Kinloch-de Loes S: Autoimmunity and HIV. CurrOpinInfectDis 2009, 22:49-56.
• [87]Mijaljica D, Prescott M, Devenish RJ: Autophagy in disease. Methods Mol Biol 2010, 648:79-92.
• [88]Zhou D, Masliah E, Spector SA: Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J Infect Dis 2011, 203:1647-1657.
• [89]Zhu Y, Vergote D, Pardo C, Noorbakhsh F, McArthur JC, Hollenberg MD, Overall CM, Power C: CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J 2009, 9:2928-2941.
• [90]McLean K, VanDeVen NA, Sorenson DR, Daudi S, Liu JR: The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells. GynecolOncol 2009, 112:623-630.
• [91]Gills JJ, Lopiccolo J, Dennis PA: Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy. Autophagy 2008, 4:107-109.
• [92]Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA: Gastrointestinal tract as a major site ofCD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431.
• [93]Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. Journal of Experimental Medicine 2004, 200:749-759.
• [94]Deeks SG, Walker BD: Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007, 27:406-416.
• [95]Killian MS, Fujimura SH, Hecht FM, Levy JA: Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. AIDS 2006, 20:1247-1252.
• [96]Edinger AL, Thompson CB: Defective autophagy leads to cancer. Cancer Cell 2003, 4:422-424.
• [97]Garcia-Arencibia M, Hochfeld WE, Toh PP, Rubinsztein DC: Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol 2010, 21:691-698.
• [98]Winslow AR, Rubinsztein DC: The Parkinson disease protein alpha-synuclein inhibits autophagy. Autophagy 2011, 7:429-431.
• [99]Lipinski MM, Hoffman G, Ng A, Zhou W, Py BF, Hsu E, Liu X, Eisenberg J, Liu J, Blenis J, et al.: A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell 2010, 18:1041-1052.
• [100]Alirezaei M, Kemball CC, Whitton JL: Autophagy, inflammation and neurodegenerative disease. Eur J Neurosci 2011, 33:197-204.
• [101]Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT: Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 2000, 97:11466-11471.
• [102]Khan NA, Di Cello F, Nath A, Kim KS: Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells. J Neurovirol 2003, 9:584-593.
• [103]Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, Huebner RE, Janoff EN, Justice AC, Kuritzkes D, et al.: Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008, 47:542-553.
• [104]Martinet W, Knaapen MW, Kockx MM, De Meyer GR: Autophagy in cardiovascular disease. Trends MolMed 2007, 13:482-491.
• [105]Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP: Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001, 56:M158-M166.
• [106]Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
• [107]Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M, Jacobson LP: Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009, 50:299-306.
• [108]Vellai T, Takacs-Vellai K, Sass M, Klionsky DJ: The regulation of aging: does autophagy underlie longevity? Trends Cell Biol 2009, 19:487-494.
• [109]Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, et al.: Novel targets for Huntington's disease in an mTORindependent autophagy pathway. Nat Chem Biol 2008, 4:295-305.
• [110]Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ: A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008, 14:90-102.
• [111]Bergamini E: Autophagy: a cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically. Mol Aspects Med 2006, 27:403-410.
• [112]Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ: Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007, 6:304-312.
• [113]Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, et al.: Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 2007, 13:5183-5194.
• [114]Roy J, Paquette JS, Fortin JF, Tremblay MJ: The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother 2002, 46(11):3447-55. 2002, 46:3447–3455
• [115]Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK, Klingebiel E, Gallo RC, Redfield RR: Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci USA 2003, 100:10411-10416.
• [116]Donia M, McCubrey JA, Bendtzen K, Nicoletti F: Potential use of rapamycin in HIV infection. Br J Clin Pharmacol 2010, 70:784-793.
• [117]Ng SS, Tsao MS, Nicklee T, Hedley DW: Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. ClinCancer Res 2001, 7:3269-3275.
• [118]Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maurice N, Mukherjee A, Goldbach C, Watkins S, et al.: An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 2010, 329:229-232.
• [119]Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005, 170:1101-1111.
• [120]Hundeshagen P, Hamacher-Brady A, Eils R, Brady NR: Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a highcontent screen for inducers of autophagy. BMC Biol 2011, 9:38. BioMed Central Full Text
• [121]Underwood BR, Imarisio S, Fleming A, Rose C, Krishna G, Heard P, Quick M, Korolchuk VI, Renna M, Sarkar S, et al.: Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum Mol Genet 2010, 19:3413-3429.
• [122]Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC: Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. JBiolChem 2007, 282:5641-5652.
• [123]Scarlatti F, Bauvy C, Ventruti A, Sala G, Cluzeaud F, Vandewalle A, Ghidoni R, Codogno P: Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J Biol Chem 2004, 279:18384-18391.
• [124]Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, Nabi IR, Roberge M: Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009, 4:e7124.
• [125]Shintani T, Klionsky DJ: Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
• [126]Donohue E, Tovey A, Vogl AW, Arns S, Sternberg E, Young RN, Roberge M: Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J Biol Chem 2011, 286:7290-7300.
• [127]Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ: The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. EurJBiochem 1997, 243:240-246.
• [128]Haspel J, Shaik RS, Ifedigbo E, Nakahira K, Dolinay T, Englert JA, Choi AM: Characterization of macroautophagic flux in vivo using a leupeptin-based assay. Autophagy 2011, 7:629-642.
• [129]Hoyvik H, Gordon PB, Berg TO, Stromhaug PE, Seglen PO: Inhibition of autophagic-lysosomal delivery and autophagic lactolysis by asparagine. J Cell Biol 1991, 113:1305-1312.
• [130]Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT: Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nature Medicine 2009, 15:267-276.